KIORA PHARMACEUTICALS, INC. Common Stock, Value, Issued
KIORA PHARMACEUTICALS, INC. (KPRX) had Common Stock, Value, Issued of $281.94 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-07
- 2026-06-30: Common Stock, Value, Issued $281.94K.
- 2026-03-31: Common Stock, Value, Issued $277.61K.
- 2025-12-31: Common Stock, Value, Issued $275.29K.
- 2025-09-30: Common Stock, Value, Issued $272.01K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $281.94K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $277.61K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $275.29K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $272.01K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $272.01K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $267.68K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $267.68K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $267.68K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $267.37K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $262.58K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $77.08K 10-K · filed 2025-03-25 | |
| 2023-09-30 | $76.92K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $69.13K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $19.21K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $17.99K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $10.79K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $130.68K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $126.64K 10-Q · filed 2022-07-08 | |
| 2021-12-31 | $3.17K 10-K · filed 2023-03-23 | $126.64K 10-K · filed 2022-04-15 |
| 2021-09-30 | $126.19K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $70.98K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $70.98K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $55.56K 10-K/A · filed 2022-07-07 | |
| 2020-09-30 | $46.27K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $46.27K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $46.27K 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $40.78K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $30.36K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $456.76K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $455.76K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $30.39K 10-K · filed 2020-03-04 | $437.94K 10-K · filed 2019-03-01 |
| 2018-09-30 | $434.44K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $423.83K 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $172.57K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $172.57K 10-K · filed 2019-03-01 | |
| 2017-09-30 | $172.05K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $172.05K 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $108.78K 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $101.31K 10-K · filed 2018-03-02 | |
| 2016-09-30 | $95.86K 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $89.52K 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $83.46K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $76.57K 10-K · filed 2017-02-23 | |
| 2015-09-30 | $76.55K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $64.77K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $63.52K 10-Q · filed 2015-05-18 | |
| 2014-12-31 | $2.02K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |